Nachrichten zu Bioalliance PharmaAct Nom. Cat-P
|
30.09.24
|
|
|
|
07.04.22
|
|
|
|
13.04.21
|
||
|
10.03.21
|
Onxeo Launches a Rights Issue to Accelerate Its R&D Programs (Businesswire)
|
|
|
09.06.20
|
||
|
13.11.19
|
||
|
04.11.19
|
||
|
03.01.19
|
||
|
18.12.18
|
||
|
05.11.18
|
||
|
18.10.18
|
||
|
27.07.18
|
||
|
12.07.18
|
||
|
15.06.18
|
||
|
15.03.18
|
||
|
25.01.18
|
||
|
23.01.18
|
Onxeo Provides Update on Litigation with SpeBio/SpePharm (Businesswire)
|
|
|
23.01.18
|
Onxeo Announces Its Financial Agenda For 2018 (Businesswire)
|
|
|
08.01.18
|
Summary of Onxeo’s Liquidity Contract With CM-CIC SECURITIES (Businesswire)
|
|
|
03.01.18
|
||
|
28.11.17
|
||
|
26.10.17
|
||
|
17.10.17
|
||
|
02.10.17
|
||
|
28.09.17
|
||
|
18.09.17
|
||
|
13.09.17
|
||
|
11.09.17
|
||
|
31.07.17
|
||
|
28.07.17
|
Onxeo Reports First-Half 2017 Results and Business Update (Businesswire)
|
|
|
06.07.17
|
Summary of Onxeo’s Liquidity Contract With CM-CIC SECURITIES (Businesswire)
|
|
|
01.03.17
|
|
|
|
09.01.17
|
Summary of Onxeo’s Liquidity Contract With CIC (Businesswire)
|
|
|
07.12.16
|
Onxeo Announces Its Financial Calendar for 2017 (Businesswire)
|
|
|
29.11.16
|
Onxeo Strengthens AsiDNATM Patent Protection in Europe (Businesswire)
|
|
|
28.11.16
|
||
|
21.11.16
|
||
|
04.11.16
|
||
|
27.10.16
|
||
|
25.10.16
|
||
|
10.10.16
|
||
|
29.09.16
|
Onxeo Launches Capital Increase (Businesswire)
|
|
|
12.09.16
|
Onxeo Announces First Outcomes of Livatag® Preclinical Plan (Businesswire)
|
|
|
07.09.16
|
||
|
28.07.16
|
||
|
27.07.16
|
||
|
07.07.16
|
||
|
04.07.16
|
||
|
27.06.16
|
||
|
02.06.16
|
Meistgelesene Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.